News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Griffin Securities Initiates Research Coverage on Oragenics, Inc. (OGEN)



11/28/2012 9:34:39 AM

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (OTCQB: OGEN) (OTCBB: OGEN) (www.oragenics.com) today announced that Griffin Securities, Inc. has initiated research coverage on the company with a BUY rating and a 12-month target price of $5.00 per share. For more information, please see the full initiation report here.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES